Literature DB >> 28830630

False positive immunoassay for acetyl choline receptor antibody (AChR Ab) in patients exposed to polyvalent antisnake venom.

Kaushik Sundar1, Shankar Venkatasubramanian2, Sundar Shanmugam2, Preetam Arthur2, Ramakrishnan Subbaraya2, Philo Hazeena2.   

Abstract

Acute flaccid paralysis is a neuromuscular emergency characterized by rapidly worsening weakness that evolves quickly to cause diaphragmatic failure. The challenge for the treating physician is to stabilize the patient, generate the differential diagnosis and determine the management; all in quick time. Neurotoxic snake bites have inadequate signs of inflammation and are easily missed. Myasthenic crisis, on the other hand, could be the first sign of myasthenia gravis in up to 20% of patients. Both present with acute respiratory failure and inadequate history. Two of our patients presented with similar clinical picture, and received polyvalent anti-snake venom obtained from hyperimmunised horses (Equus caballus). Both tested positive for anti-acetyl choline receptor antibody. After recovery, both patients narrated a history suggestive of neurotoxic envenomation. We later discovered that patients, who are exposed to polyvalent anti-snake venom (Equus caballus) prior to radioimmunoassay, demonstrate high titers of Anti-AChR Ab in their serum erroneously.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-acetyl choline receptor antibody; Anti-snake venom; False positive; Myasthenic crisis; Radioimmunoassay

Mesh:

Substances:

Year:  2017        PMID: 28830630     DOI: 10.1016/j.jneuroim.2017.08.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  1 in total

1.  Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder.

Authors:  Carolin Hoffmann; Jo Stevens; Shenghua Zong; Daan van Kruining; Abhishek Saxena; Cem İsmail Küçükali; Erdem Tüzün; Nazlı Yalçınkaya; Marc De Hert; Emiliano González-Vioque; Celso Arango; Jon Lindstrom; Marc H De Baets; Bart P F Rutten; Jim van Os; Peter Molenaar; Mario Losen; Pilar Martinez-Martinez
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.